Private Advisor Group, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1567755
MORRISTOWN, NJ
Position in VRTX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,051,494
-$1,714,177 QoQ
Shares Held
4,130
-51.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#671
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2023CallValue
$1,739
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. VRTX ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,557 | $11,571,031 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
111,129 | $6,060,975 | |
| 3 | CRMD |
CorMedix Inc.
|
415,406 | $3,260,937 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
30,352 | $2,473,991 | |
| 5 | TLX |
Telix Pharmaceuticals Ltd
|
197,250 | $2,274,292 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
4,130 | $2,051,494 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
165,954 | $1,452,927 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
504,000 | $1,305,360 |
All Filings in VRTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,051,494 | 4,130 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,765,671 | 8,433 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,941,511 | 8,694 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,884,036 | 7,364 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,207,220 | 7,204 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,612,878 | 7,452 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,903,467 | 7,210 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,369,039 | 7,244 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $3,853,347 | 8,221 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,334,883 | 7,978 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $4,199,511 | 10,321 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,739 | 500 | Call | Sole | 2023-11-03 | |
| 2023-09-30 | $3,415,154 | 9,821 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $4,474,535 | 12,715 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,929,488 | 6,124 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,113,003 | 7,317 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $1,679,332 | 5,800 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $8,952,750 | 31,771 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $7,728,887 | 29,616 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,802,988 | 30,979 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,783,075 | 31,882 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $5,630,921 | 27,927 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,480,905 | 11,545 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $2,400,269 | 10,156 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $2,447,447 | 8,994 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,088,780 | 7,195 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,178,090 | 4,951 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||